Metabolic Disorders and TPE, Therapeutic plasma exchange, Clinical Pathology - Full Vignette with Ex скачать в хорошем качестве

Metabolic Disorders and TPE, Therapeutic plasma exchange, Clinical Pathology - Full Vignette with Ex

A 55-year-old woman with chronic kidney disease, heart failure, and allergic rhinitis presents with acute fever, agitation, palpitations, diarrhea, and rapidly worsening shortness of breath. Her exam shows new atrial fibrillation, profound thyroid enlargement, tremor, and clinical instability despite standard therapies. Laboratory tests reveal significant thyroid hormone derangements. How do these clinical findings help guide advanced management decisions in severe thyroid-related emergencies, and what unique challenges might you encounter in this scenario? VIDEO INFO Category: Metabolic Disorders and TPE, Therapeutic plasma exchange, Clinical Pathology Difficulty: Moderate - Intermediate level - Requires solid foundational knowledge Question Type: Mechanism Case Type: Typical Presentation Explore more ways to learn on this and other topics by going to https://endlessmedical.academy/auth?h... QUESTION A 55-year-old woman with autosomal dominant polycystic kidney disease, heart failure with reduced ejection fraction, and seasonal allergic rhinitis presents with fever, agitation, palpitations, diarrhea, and dyspnea. She lives in assisted living and is 5 years sober from prior cocaine, methamphetamine, and alcohol use. Over the prior 3 weeks she has had heat intolerance, tremor, insomnia, and unintentional 4-lb weight loss with a rapid worsening today.... OPTIONS A. Therapeutic plasma exchange at 1.0-1.5 plasma volumes ( 2.7-4.1 L for a 68-kg woman with hematocrit 0.38) using 5% albumin with limited plasma as needed, with regional citrate anticoagulation in the ICU, rapidly removes predominantly protein-bound T4 and T3 from plasma and increases unsaturated b... B. Therapeutic plasma exchange at 1.0 plasma volume using fresh frozen plasma replacement mainly enhances hepatic metabolic clearance of T3 and T4, and a single session is generally sufficient to normalize thyroid levels without additional therapies. C. Continuous plasma exchange at 0.5 plasma volumes with full fresh frozen plasma replacement works primarily by blocking intrathyroidal organification and inhibiting peripheral deiodinases, making further antithyroid drugs unnecessary after the first run. D. Double-filtration plasmapheresis at 1.0-1.5 plasma volumes using albumin replacement is considered equivalent to therapeutic plasma exchange for rapid free T4 reduction in most situations, so a single session in the ICU is usually adequate despite limited comparative evidence. CORRECT ANSWER A. Therapeutic plasma exchange at 1.0-1.5 plasma volumes ( 2.7-4.1 L for a 68-kg woman with hematocrit 0.38) using 5% albumin with limited plasma as needed, with regional citrate anticoagulation in the ICU, rapidly removes predominantly protein-bound T4 and T3 from plasma and increases unsaturated binding capacity, lowering free hormone levels; perform daily or every-other-day sessions until clinical control. EXPLANATION Severe thyrotoxicosis with hemodynamic instability despite full medical therapy may require extracorporeal support. Therapeutic plasma exchange (TPE) rapidly lowers circulating thyroid hormones primarily by removing the protein-bound intravascular pool of thyroxine (T4) and triiodothyronine (T3) and by increasing unsaturated binding capacity when albumin is used as replacement. Because over 99% of T4 and T3 are protein-bound, TPE can substantially decrease total hormone levels within hours, which reduces free fractions as binding equilibrates to newly available sites on infused albumin.... Further reading: Links to sources are provided for optional further reading only. The questions and explanations are independently authored and do not reproduce or adapt any specific third-party text or content. --------------------------------------------------- Our cases and questions come from the https://EndlessMedical.Academy quiz engine - multi-model platform. Each question and explanation is forged by consensus between multiple top AI models (i.e. Open AI GPT, Claude, Grok, etc.), with automated web searches for the latest research and verified references. Calculations (e.g. eGFR, dosages) are checked via code execution to eliminate errors, and all references are reviewed by several AIs to minimize hallucinations. Important note: This material is entirely AI-generated and has not been verified by human experts; despite stringent consensus checks, perfect accuracy cannot be guaranteed. Exercise caution - always corroborate the content with trusted references or qualified professionals, and never apply information from this content to patient care or clinical decisions without independent verification. Clinicians already rely on AI and online tools - myself included - so treat this content as an additional focused aid, not a replacement for proper medical education. Visit https://endlessmedical.academy for more AI-supported resources and cases. This material can not be treated as medical advice. May contain errors. --------...